SSS17
SYSS-SSS17-RA-II-01
Phase 2 small_molecule completed
Quick answer
SSS17 for Anemia in Pre-Dialysis Patients is a Phase 2 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Anemia in Pre-Dialysis Patients
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed